Boston Scientific Newsroom

Equities Largely Unchanged After Labor Market Data, Fed Governor Remarks

MT Newswires14:09 ET

Johnson & Johnson Falls After Pausing Varipulse Cases

Seeking Alpha13:31 ET

Express News | CNBC Halftime Report Final Trades: Apollo Global Management, UnitedHealth Group, IShares U.S. Financial ETF, Boston Scientific

Benzinga13:00 ET

Needham Maintains Boston Scientific(BSX.US) With Hold Rating

Moomoo News11:32 ET · Ratings

Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock

Kevin Travers11:06 ET

U.S. stocks movement | Agreement reached to acquire Bolt Medical, Boston Scientific (BSX.US) rises nearly 5%.

On Wednesday, Boston Scientific (BSX.US) rose by nearly 5%, reaching a new historical high of $96.42.

Zhitong FinanceJan 8 10:38 ET

AAR Posts Upbeat Results, Joins AngioDynamics, EBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday

BenzingaJan 8 10:07 ET

BTIG Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $101

Moomoo NewsJan 8 09:34 ET · Ratings

Sector Update: Health Care Stocks Rise Premarket Wednesday

MT NewswiresJan 8 09:19 ET

Boston Scientific Corporation (BSX) Hits Fresh High: Is There Still Room to Run?

Yahoo FinanceJan 8 09:15 ET

Hysteroscopy Instruments Market Research 2024-2028 & 2033 Featuring Major Players - Medtronic, Fujifilm, Stryker, Boston Scientific, and B. Braun Melsungen

Yahoo FinanceJan 8 09:14 ET

Implantable Neurostimulation Devices Market Research 2024-2028 & 2033, Competitive Analysis of Major Players - Abbott Laboratories, Medtronic, Boston Scientific, Dignity Health, & St. Jude Medical

Yahoo FinanceJan 8 09:10 ET

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of FOMC Meeting Minutes

MT NewswiresJan 8 08:12 ET

CCORF Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $101

Moomoo NewsJan 8 07:34 ET · Ratings

Bernstein Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100

Moomoo NewsJan 8 07:34 ET · Ratings

Boston Scientific Sees Deal Slightly Dilutive to Adj EPS in 2025 >BSX

Dow JonesJan 8 07:09 ET

Boston Scientific: Buyout to Expand Cardiovascular Portfolio With Complementary, Differentiated Calcium Modification Platform >BSX

Dow JonesJan 8 07:07 ET

Positive Long-Term Outlook for Boston Scientific Post-Axonics Acquisition: Buy Rating Affirmed

TipRanksJan 8 07:06 ET · Ratings

Boston Scientific Enters Definitive Deal To Acquire Bolt Medical; Transaction Consists Of Upfront Payment Of $443M For The 74% Stake Not Yet Owned

BenzingaJan 8 07:02 ET

Express News | Boston Scientific Corp - Deal Valued at $443 Million Upfront, up to $221 Million in Milestones

ReutersJan 8 07:00 ET